Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-30

Clinical Trial Update: Sutent Rechallenge In mRCC Patients

View source ↗

Summary

The document reports the completion and posted results of a clinical trial evaluating rechallenge with Sutent (sunitinib) in patients with metastatic renal cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sutent (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Metastatic Renal Cell Carcinoma | Status: COMPLETED | Results posted: 2015-04-30